- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Sensory modality.
Displaying page 1 of 1.
EudraCT Number: 2017-002024-24 | Sponsor Protocol Number: AUH-2016-100 | Start Date*: 2017-09-08 | |||||||||||
Sponsor Name:Aarhus Unversity Hospital | |||||||||||||
Full Title: Randomized, cohort study of standardized reduction of subcutaneous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy | |||||||||||||
Medical condition: Chronic inflammatory demyelinating polyneuroapthy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001072-21 | Sponsor Protocol Number: MKN106762 | Start Date*: 2006-08-08 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: A double-blind placebo-controlled study of the efficacy and safety of the P38 Map Kinase inhibitor SB681323 in patients with neuropathic pain following nerve trauma | ||
Medical condition: Neuropathic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003242-34 | Sponsor Protocol Number: 67103 | Start Date*: 2005-11-21 | |||||||||||
Sponsor Name:National Institutes of Neurological Disorders: Stroke | |||||||||||||
Full Title: Secondary Prevention of Small Subcortical Strokes | |||||||||||||
Medical condition: Secondary prevention of small subcortical strokes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003210-33 | Sponsor Protocol Number: ERPME01 | Start Date*: 2007-08-03 | |||||||||||
Sponsor Name:Department of Neurology, Turku University Hospital | |||||||||||||
Full Title: Effect of ropinirole hydrochloride in progressive myoclonic epilepsy of Unverricht–Lundborg type | |||||||||||||
Medical condition: Progressive myoclonus epilepsy of the Unverricht–Lundborg disease (ULD) type | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004812-73 | Sponsor Protocol Number: BP18-1-501 | Start Date*: 2022-05-16 |
Sponsor Name:Leiden University | ||
Full Title: The influence of pharmacological conditioning with S-ketamine on pain sensitivity in patients with Fibromyalgia Syndrome | ||
Medical condition: Fibromyalgia Syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
